Journal of Nuclear Medicine: 65 (9)

September 1, 2024; Volume 65,Issue 9

This Month in JNM

You have access
This Month in JNM
Journal of Nuclear Medicine September 1, 2024, 65 (9) 8A;

Editor’s Page

You have access
FINDing the Future of Radiopharma
Christian Behrenbruch

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1333-1335; DOI: https://doi.org/10.2967/jnumed.124.268303

The State of the Art

You have access
Paraplegic Patient with Metastatic Papillary Thyroid Cancer: A Multidisciplinary Approach to Radioactive Iodine Therapy Safety and Efficacy Strategy
Ghadah Al-Naqeeb, Eric Munger, Amrita L. Ramanathan, Andrew Makarewicz, Noha Behairy, Padmasree Veraraghavan, Craig Cochran, Philip Bernaldez, Iman Clinton, Newbegin Devaraj, Korressa Lee, Teresa Fisher, Olumide Owoade, Roberto Maass-Moreno, Babak Saboury, Sriram Gubbi and Joanna Klubo-Gwiezdzinska

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1336-1339; DOI: https://doi.org/10.2967/jnumed.123.266955

Is It Really Happening?

Open Access
¹⁷⁷Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?
Andreas Poschenrieder, Jasminka Taleska and Leonhard Schaetz

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1340-1342; DOI: https://doi.org/10.2967/jnumed.124.267951

Oncology

Clinical
- Open Access
  International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline ¹⁸F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation
  Ronald Boellaard, Irène Buvat, Christophe Nioche, Luca Ceriani, Anne-Ségolène Cottereau, Luca Guerra, Rodney J. Hicks, Salim Kanoun, Carsten Kobe, Annika Loft, Heiko Schöder, Annibale Versari, Conrad-Amadeus Voltin, Gerben J.C. Zwezerijnen, Josée M. Zijlstra, N. George Mikhaeel, Andrea Gallamini, Tarec C. El-Galaly, Christine Hanoun, Stephane Chauvie, Romain Ricci, Emanuele Zucca, Michel Meignan and Sally F. Barrington
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1343-1348; DOI: https://doi.org/10.2967/jnumed.124.267789
- Open Access
  Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?
  Semra Ince, Richard Laforest, Malak Itani, Vikas Prasad, Paul-Robert Derenoncourt, John P. Crandall, Saeed Ashrafinia, Anne M. Smith, Richard L. Wahl and Tyler J. Fraum
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1349-1356; DOI: https://doi.org/10.2967/jnumed.123.266469
- You have access
  Role of ⁶⁴CuCl₂ PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and ¹⁸F-FDG PET/CT
  Arnoldo Piccardo, Gianluca Bottoni, Cristina Puppo, Michela Massollo, Martina Ugolini, Mehrdad Shoushtari Zadeh Naseri, Enrico Melani, Laura Tomasello, Monica Boitano, Andrea DeCensi, Beatrice Sambucco, Fabio Campodonico, Vania Altrinetti, Marco Ennas, Alessia Urru, Carlo Luigi Augusto Negro, Luca Timossi, Giorgio Treglia, Carlo Introini and Francesco Fiz
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1357-1363; DOI: https://doi.org/10.2967/jnumed.124.267474
- You have access
  Theranostic Intratumoral Convection-Enhanced Delivery of ¹²⁴I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry
  Neeta Pandit-Taskar, Pat B. Zanzonico, Milan Grkovski, Maria Donzelli, Scott M. Vietri, Christopher Horan, Brian Serencsits, Kavya Prasad, Serge Lyashchenko, Kim Kramer, Ira J. Dunkel and Mark M. Souweidane
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1364-1370; DOI: https://doi.org/10.2967/jnumed.123.266365
- You have access
  Utility of ⁶⁴Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on ⁶⁸Ga-PSMA-11 PET/CT
  Sherrington Li, Andrew Nguyen, William Counter, Nikeith C. John, Jeremiah De Leon, George Hruby, Anthony M. Joshua, Phillip Stricker, Megan Crumbaker, Narjess Ayati, Lyn Chan, Zahra Sabahi, Mina Swiha, Andrew Kneebone, Keith Wong, Victor Liu, Shikha Sharma, Shikha Agrawal and Louise M. Emmett
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1371-1375; DOI: https://doi.org/10.2967/jnumed.124.267881
- You have access
  [⁶⁸Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria
  Ismini C. Mainta, Angeliki Neroladaki, Nicola Bianchetto Wolf, Daniel Benamran, Sana Boudabbous, Thomas Zilli and Valentina Garibotto
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1376-1382; DOI: https://doi.org/10.2967/jnumed.124.267899
- BRIEF COMMUNICATION
  - Open Access
    ¹⁸F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology
    Medhat M. Osman, Amir Iravani, Catherine Mitchell, Rodney J. Hicks, Elisa Perry and Michael S. Hofman
    
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1383-1386; DOI: https://doi.org/10.2967/jnumed.124.267772

Theranostics

Clinical
- You have access
  Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
  John Nikitas, Angela Castellanos Rieger, Andrea Farolfi, Ameen Seyedroudbari, Amar U. Kishan, Nicholas G. Nickols, Michael L. Steinberg, Luca F. Valle, Matthew Rettig, Johannes Czernin and Jeremie Calais
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1387-1394; DOI: https://doi.org/10.2967/jnumed.124.267922
- You have access
  Impact of Posttreatment SPECT/CT on Patient Management During ¹⁷⁷Lu-PSMA-617 Radiopharmaceutical Therapy
  Surekha Yadav, Blair Lowery, Abuzar Moradi Tuchayi, Fei Jiang, Rachelle Saelee, Rahul R. Aggarwal, Roxanna Juarez, Robert R. Flavell and Thomas A. Hope
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1395-1401; DOI: https://doi.org/10.2967/jnumed.124.267955
- You have access
  Neurologic Symptoms After ¹⁷⁷Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
  Gokce Belge Bilgin, Brian J. Burkett, Cem Bilgin, Jacob J. Orme, Daniel S. Childs, Miguel Muniz Rincon, Ahmad S. Abdelrazek, Derek R. Johnson, Geoffrey B. Johnson, Eugene D. Kwon, Oliver Sartor and Ayse Tuba Kendi
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1402-1408; DOI: https://doi.org/10.2967/jnumed.124.267643
- $Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up$
  
  Open Access
  Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up
  Stefano Severi, Ilaria Grassi, Alberto Bongiovanni, Silvia Nicolini, Irene Marini, Donatella Arpa, Nicoletta Ranallo, Irene Azzali, Valentina Di Iorio, Anna Sarnelli, Monti Manuela, Elena Amadori, Lucia Fabbri, Daniela Bartolini, Luigino Tosatto, Francesco Di Meco, Lorena Gurrieri, Nada Riva, Luana Calabro, Federica Matteucci, Giovanni Paganelli and Maddalena Sansovini
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1409-1415; DOI: https://doi.org/10.2967/jnumed.123.266956
- FEATURED ARTICLE OF THE MONTH
  - You have access
    Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network
    Aurelien Fosse, Julien Hadoux, Paul Girot, Amandine Beron, Pauline Afchain, Anne-Segolene Cottereau, Eric Baudin, Lawrence O. Dierickx, Thierry Lecomte, Marine Perrier, Come Lepage, Karine Bouhier-Leporrier, Bernard Goichot, Boumediene Lachachi, Thomas Walter and Alice Durand
    
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1416-1422; DOI: https://doi.org/10.2967/jnumed.123.267363
- BRIEF COMMUNICATION
  - You have access
    Elevated Baseline Mean Corpuscular Volume Predicts the Development of Severe Hematologic Toxicity After ¹⁷⁷Lu-DOTATATE Therapy
    Andrew F. Voter, Andrei Gafita, Rudolf A. Werner, Ana De Jesus-Acosta, Steven P. Rowe and Lilja B. Solnes
    
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1423-1426; DOI: https://doi.org/10.2967/jnumed.124.267462
Translational
- Open Access
  ⁶¹Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging
  Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, Sandra Zanger, Raghuvir H. Gaonkar, Lisa McDougall, Francesco De Rose, Leila Jaafar-Thiel, Michael Herz, Matthias Eiber, Gary A. Ulaner, Wolfgang A. Weber and Melpomeni Fani
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1427-1434; DOI: https://doi.org/10.2967/jnumed.123.267126
Basic
- Open Access
  Single Chelator–Minibody Theranostic Agents for ⁸⁹Zr PET Imaging and ¹⁷⁷Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer
  Khanh-Van Ho, David S. Tatum, Lisa Watkinson, Terry Carmack, Fang Jia, Alessandro Mascioni, Charles A. Maitz, Darren Magda and Carolyn J. Anderson
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1435-1442; DOI: https://doi.org/10.2967/jnumed.124.267667
- You have access
  ²¹¹At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation
  Sofia H.L. Frost, Johnnie J. Orozco, Tom A. Bäck, Brian W. Miller, Erlinda B. Santos, Aimee Kenoyer, Sue E. Knoblaugh, Donald K. Hamlin, D. Scott Wilbur and Brenda M. Sandmaier
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1443-1449; DOI: https://doi.org/10.2967/jnumed.124.267540

Radionuclide Therapy

Clinical
- Open Access
  Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study
  Siddhartha Baxi, Saima Vohra, Angela Hong, Nicola Mulholland, Martin Heuschkel, Gerhard Dahlhoff, Giuseppe Cardaci, Siroos Mirzaei and Mike Sathekge
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1450-1455; DOI: https://doi.org/10.2967/jnumed.124.267988
Basic
- You have access
  Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of ²²⁵Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models
  Christian W. Wichmann, Katherine A. Morgan, Zhipeng Cao, Laura D. Osellame, Nancy Guo, Hui Gan, Edward Reilly, Ingrid J.G. Burvenich, Graeme J. O’Keefe, Paul S. Donnelly and Andrew M. Scott
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1456-1462; DOI: https://doi.org/10.2967/jnumed.123.266894

Neurology

Basic
- BRIEF COMMUNICATION
  - You have access
    Unrealistic Data Augmentation Improves the Robustness of Deep Learning–Based Classification of Dopamine Transporter SPECT Against Variability Between Sites and Between Cameras
    Thomas Buddenkotte and Ralph Buchert
    
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1463-1466; DOI: https://doi.org/10.2967/jnumed.124.267570
- FEATURED BASIC SCIENCE ARTICLE
  - You have access
    Development of a ²¹³Bi-Labeled Pyridyl Benzofuran for Targeted α-Therapy of Amyloid-β Aggregates
    Aidan A. Bender, Emily K. Kirkeby, Donna J. Cross, Satoshi Minoshima, Andrew G. Roberts and Tara E. Mastren
    
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1467-1472; DOI: https://doi.org/10.2967/jnumed.124.267482

AI/Advanced Image Analysis

Basic
- You have access
  Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure
  Robel K. Gebre, Alexis Moscoso Rial, Sheelakumari Raghavan, Heather J. Wiste, Fiona Heeman, Alejandro Costoya-Sánchez, Christopher G. Schwarz, Anthony J. Spychalla, Val J. Lowe, Jonathan Graff-Radford, David S. Knopman, Ronald C. Petersen, Michael Schöll, Melissa E. Murray, Clifford R. Jack, Prashanthi Vemuri and for the Alzheimer’s Disease Neuroimaging Initiative
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1473-1480; DOI: https://doi.org/10.2967/jnumed.123.267273

Physics and Instrumentation

Clinical
- Open Access
  Total-Body Dynamic Imaging and Kinetic Modeling of [¹⁸F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy
  Negar Omidvari, Jelena Levi, Yasser G. Abdelhafez, Yiran Wang, Lorenzo Nardo, Megan E. Daly, Guobao Wang and Simon R. Cherry
  
  Journal of Nuclear Medicine September 1, 2024, 65 (9) 1481-1488; DOI: https://doi.org/10.2967/jnumed.123.267003
Basic
- BRIEF COMMUNICATION
  - Open Access
    StepBrain: A 3-Dimensionally Printed Multicompartmental Anthropomorphic Brain Phantom to Simulate PET Activity Distributions
    Maria Agnese Pirozzi, Valeria Gaudieri, Anna Prinster, Mario Magliulo, Alberto Cuocolo, Arturo Brunetti, Bruno Alfano and Mario Quarantelli
    
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1489-1492; DOI: https://doi.org/10.2967/jnumed.123.267277

The Illustrated Post

You have access
[¹⁷⁷Lu]Lu-Prostate-Specific Membrane Antigen-617 in a Patient with Metastatic Castration-Resistant Prostate Cancer and Status After Bilateral Nephrectomy
Yu-Yi Huang, Ting-Chum Lin, Shih-Han Yang, Lan-Shih Lai, Ling-Man Hung, Ming-Hsin Li and Kuo-Cheng Huang

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1493; DOI: https://doi.org/10.2967/jnumed.124.267533
You have access
[¹⁷⁷Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy: Initial Clinical Experience in Renal Carcinoid
Akram Al-Ibraheem, Ahmed Abdlkadir, Dhuha Al-Adhami and Ken Herrmann

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1494; DOI: https://doi.org/10.2967/jnumed.124.267497

Letter to the Editor

You have access
The Potential Value of Functional Adrenal Imaging in Primary Aldosterone
Benjamin L. Viglianti and Allen Brooks

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1495; DOI: https://doi.org/10.2967/jnumed.124.267966
You have access
Reply: The Potential Value of Functional Adrenal Imaging in Primary Aldosterone
Xiang Li and Li Huo

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1495-1496; DOI: https://doi.org/10.2967/jnumed.124.268001
You have access
Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions
Loic Ah-Thiane, Ludovic Ferrer, Stéphane Supiot and Caroline Rousseau

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1496-1497; DOI: https://doi.org/10.2967/jnumed.124.267477
You have access
Reply: Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions
Jan J. Duin, Hilda A. de Barros, Pim J. van Leeuwen and Henk G. van der Poel

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1497; DOI: https://doi.org/10.2967/jnumed.124.267658

In Memoriam

You have access
Robert Carretta, MD, 1941–2023
Journal of Nuclear Medicine September 1, 2024, 65 (9) 1498;

Main menu

User menu

Search

Table of Contents

This Month in JNM

Editor’s Page

The State of the Art

Is It Really Happening?

Oncology

Clinical

BRIEF COMMUNICATION

Theranostics

Clinical

FEATURED ARTICLE OF THE MONTH

BRIEF COMMUNICATION

Translational

Basic

Radionuclide Therapy

Clinical

Basic

Neurology

Basic

BRIEF COMMUNICATION

FEATURED BASIC SCIENCE ARTICLE

AI/Advanced Image Analysis

Basic

Physics and Instrumentation

Clinical

Basic

BRIEF COMMUNICATION

The Illustrated Post

Letter to the Editor

In Memoriam

In this issue

Issue highlights

Jump to